Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: Refined selection criteria

Clinical Transplantation

Volumn 28, Issue 6, 2014, Pages 728-736

  Kashkoush, Samy ^a,b   El Moghazy, Walid ^a,c   Kawahara, Toshiyasu ^a   Gala Lopez, Boris ^a   Toso, Christian ^a,d   Kneteman, Norman M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MENOUFIA UNIVERSITY   (Egypt)

^c SOHAG UNIVERSITY   (Egypt)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Liver transplantation; Recurrence; Tumor volume

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; TUMOR VOLUME; UNIVERSITY HOSPITAL; BLOOD; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR BURDEN;

EID: 84901832096     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12373     Document Type: Article

References (36)

1. Frangakis C, Geschwind JF, Kim D et al. Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. Cardiovasc Intervent Radiol 2011: 34: 1254.
2. Mirza DF, Goetzinger P, Fuegger R, Wamser P, Steininger R, Muehlbacher F. Orthotopic liver transplantation in the management of end stage liver disease: the University of Vienna experience. Indian J Gastroenterol 1991: 10: 92.
3. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993: 218: 145.
4. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693.
5. Mazzaferro V, Bhoori S, Sposito C et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011: 17(Suppl 2): S44.
6. Yao FY. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Hepatol Res 2007: 37(Suppl 2): S267.
7. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001: 33: 1394.
8. Herrero JI, Sangro B, Pardo F et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008: 14: 272.
9. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007: 13: 391.
10. Ito T, Takada Y, Ueda M et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007: 13: 1637.
11. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007: 25: 310.
12. Lee SG, Hwang S, Moon DB et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008: 14: 935.
13. Silva M, Moya A, Berenguer M et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008: 14: 1449.
14. Mazzaferro V, Llovet JM, Miceli R et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009: 10: 35.
15. Lai Q, Avolio AW, Graziadei I et al. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl 2013: 19: 1108.
16. Lai Q, Avolio AW, Lerut J et al. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in east and west. J Hepatol 2012: 57: 974.
17. Kwon CH, Kim DJ, Han YS et al. HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 2007: 25: 313.
18. Zheng SS, Xu X, Wu J et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008: 85: 1726.
19. Takada Y, Ito T, Ueda M et al. 2007. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis (Basel, Switzerland) 25:299.
20. Toso C, Trotter J, Wei A et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008: 14: 1107.
21. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009: 49: 832.
22. Liess H, Roth C, Umgelter A, Zoller WG. Improvements in volumetric quantification of circumscribed hepatic lesions by three dimensional sonography. Z Gastroenterol 1994: 32: 488.
23. Wolf GK, Lang H, Prokop M, Schreiber M, Zoller W. Volume measurements of localized hepatic lesions using three-dimensional sonography in comparison with three-dimensional computed tomography. Eur J Med Res 1998: 3: 157.
24. Lang H, Wolf GK, Prokop M, Weimann A, Pichlmayr R, Zoller WG. Volumetry of circumscribed liver changes with 3-D ultrasound in comparison with 3-D computerized tomography. Langenbecks Arch Chir Suppl Kongressbd 1998: 115: 1478.
25. Lang H, Wolf GK, Prokop M et al. 3-dimensional sonography for volume determination of liver tumors-report of initial experiences. Der Chirurg 1999: 70: 246.
26. Lee DH, Kim SH, Lee JM et al. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009: 44: 311.
27. Becker-Weidman DJ, Kalb B, Sharma P et al. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging-comparison to prior same-center results after MR systems improvements. Radiology 2011: 261: 824.
28. Meier S, Schenk A, Mildenberger P, Bourquain H, Pitton M, Thelen M. Evaluation of a new software tool for the automatic volume calculation of hepatic tumors. First results. RoFo 2004: 176: 234.
29. Keil S, Plumhans C, Behrendt FF et al. Semi-automated quantification of hepatic lesions in a phantom. Invest Radiol 2009: 44: 82.
30. Puesken M, Juergens KU, Edenfeld A et al. Accuracy of liver lesion assessment using automated measurement and segmentation software in biphasic multislice CT (MSCT). RoFo 2009: 181: 67.
31. Zheng SS, Xu X, Liang TB et al. Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases. Zhonghua Wai Ke Za Zhi 2005: 43: 450.
32. Toso C, Mentha G, Majno P. Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology? Hepatobiliary Pancreat Dis Int 2010: 9: 460.
33. Furukawa H, Shimamura T, Suzuki T et al. Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Sci 2010: 17: 533.
34. Lai Q, Avolio AW, Manzia TM et al. Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? Int J Biol Markers 2011: 26: 153.
35. Coenegrachts K, Delanote J, Ter Beek L et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007: 80: 524.
36. Yu JS, Chung JJ, Kim JH et al. Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI. Magn Reson Imaging 2011: 29: 985.